Current Projects:
- SDF-1: a diagnostic and therapy-specific Biomarker for AKI
- The impact of uremic Serum on the Bioenergetics of Renal and Stem Cell Mitochondria
- Treatment of CKD and AKI on CKD with allogeneic Stem Cells
- Stem Cell Technology for the Cure of experimental T1DM
- Stem Cell Technology for the Treatment of experimental Parkinson’s disease
Current Funding:
- VA Central Office Merit review grant: SDF-1: a diagnostic and therapy-specific Biomarker for AKI
- O’Brien Center, UAB and UCSD and WIBR grants: The impact of uremic Serum on the Bioenergetics of Renal and Stem Cell Mitochondria
- TCIP Grant, State of Utah: Stem Cell Technology for the Cure of T1DM
- University of Utah, Research Foundation Seed grant: Stimulation of renal Erythropoietin Production with an oral Polypeptide